BTG2 - morinlab/LLMPP GitHub Wiki


bibliography: 'morinlab.bib' csl: 'NLM.csl' link-citations: true nocite: | @morinFrequentMutationHistonemodifying2011, @loveGeneticLandscapeMutations2012,

TOC

Overview

BTG2 is one of a number of genes affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. Mutations in the BTG2 gene have been implicated in the pathogenesis of diffuse large B-cell lymphoma (DLBCL), contributing to the development and progression of the disease. These mutations are a feature of the MCD genetic subgroup of DLBCL. The biological function of BTG2 mutations and their role in lymphomagenesis remains poorly understood. Due to minimal support in the original primary data and very few mutations reported in subsequent studies, this gene is very unlikely to be relevant in BL.

Relevance tier by entity

include:tables/table1_BTG2.md

Warnings

<<Warn("The variants reported in this gene in BL failed QC")>>

Mutation incidence in large patient cohorts (GAMBL reanalysis)

DLBCL

include:tables/DLBCL_BTG2.md

FL

include:tables/FL_BTG2.md

Mutation pattern and selective pressure estimates

include:tables/dnds_BTG2.md

aSHM regions

chr_name hg19_start hg19_end region regulatory_comment
chr1 203274698 203275778 intron active_promoter

include:tables/browser_BTG2.md

Expression

Representative Mutations

BL[@loveGeneticLandscapeMutations2012]

Rating ★ ★ ☆ ☆ ☆

All Mutations

BL[@loveGeneticLandscapeMutations2012]

1065 1098 321 323 323

include:tables/mermaid_BTG2.md

References